• <blockquote id="kzik6"></blockquote>
    <blockquote id="kzik6"></blockquote>
    日本久久99成人网站,在线观看美女网站大全免费,亚洲制服另类无码专区,看国产黄大片在线观看,欧美屁股大的xxxxx,精品国产av色欲果冻传媒,最近中文字幕完整国语,国产精品18久久久久久麻辣
    您好!歡迎訪問上海起發(fā)實驗試劑有限公司網(wǎng)站!
    全國服務(wù)咨詢熱線:

    15921799099

    當(dāng)前位置:首頁 > 技術(shù)文章 > JCRB細(xì)胞庫 JCRB0086

    JCRB細(xì)胞庫 JCRB0086

    更新時間:2020-02-14      點擊次數(shù):12996

    JCRB細(xì)胞庫,正在收集各種人類和動物培養(yǎng)細(xì)胞,包括癌癥和轉(zhuǎn)基因細(xì)胞。細(xì)胞資源被分配給日本乃至*的研究人員。這些細(xì)胞通過測試微生物污染,病毒污染和交叉培養(yǎng)物污染而獲得全面認(rèn)證。一些細(xì)胞的特征是核型分析和/或細(xì)胞表面標(biāo)記。我們與世界上其他主要的細(xì)胞庫合作,正在開發(fā)細(xì)胞培養(yǎng)和質(zhì)量控制方法,以支持藥物科學(xué)醫(yī)學(xué)的基礎(chǔ)研究。

     

     

    恭喜上海起發(fā)cellbank 細(xì)胞報關(guān),順利通關(guān)!

    JCRB細(xì)胞庫  JCRB0086 [TALL-1]

    接受日期:1986年5月15日
    動物:人的
    性別和年齡:男:28歲
    科學(xué)名稱:智人 智人
    病歷:急性淋巴細(xì)胞白血病
    分類:
    組織準(zhǔn)備:骨髓
    腫瘤起源:骨髓
    開始細(xì)胞培養(yǎng)的日期:05/16/86
    細(xì)胞的歷史:三宅一生=> NIHS(JCRB)
    介質(zhì):含10%胎牛血清的RPMI1640培養(yǎng)基
    通道方法:稀釋。
    CO 2濃度:5%
    單元號 通過時:5x10 ^ 5細(xì)胞/ ml
    遺傳學(xué):T細(xì)胞
    壽命:無窮
    形態(tài)學(xué):淋巴細(xì)胞樣
    特點:T細(xì)胞淋巴細(xì)胞白血病。模式= 95-101
    小區(qū)ID數(shù)據(jù):可用的
    DNA譜(STR):D5S818:9,12 
    D13S317:8,9 
    D7S820:10,11 
    D16S539:9,10 
    VWA:17,19 
    TH01:7,9 
    Amelogenin:X,Y 
    TPOX:8,11 
    CSF1PO:11,13
    檢測到的病毒DNA:CMV(-),EBV(-),HHV6(-),HHV7(-),BKV(-),JCV(-),ADV(-),parvoB19(-),HBV(-),HTLV1(-), HTLV2(-),HIV1(-),HIV2(-),HPV18(nt)[-/陰性,+ /陽性,nt /未測試]- 說明
    建立者Hiraki,S.
    存入者Miyoshi,I.
    單元庫:NIHS(JCRB)

     

    批號:052386:代幣/種子(JCRB0086)]
     
    • 從庫存中繁殖細(xì)胞,傳代號052386 
       P3 * 
      細(xì)胞培養(yǎng)的開始日期: 05/30/86 
      安瓿中細(xì)胞的濃度: 7.5x10 ^ 5細(xì)胞/ ml 
      顯微鏡下的存活率(%): 98%
      使用的抗生素:免費
      支原體,細(xì)菌和真菌的檢測結(jié)果均為陰性。經(jīng)測試同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。 







    •  
    •  
    •  
    •  
    •  
    •  

    [這批的文化條件。

    • 培養(yǎng)基: 含10%胎牛血清的RPMI1640培養(yǎng)基。傳代
      方法: 稀釋。
      生長溫度: 37 
      細(xì)胞編號: 5x10 ^ 5細(xì)胞/ ml 
      備注:在安瓿瓶上批號:052386。
      補充說明: 冷凍前的生存力為99%。在10/20/87檢查生存力。
    批號:071286:分銷(JCRB0086)]
     
    • 傳代號, P6 * 
      細(xì)胞培養(yǎng)的開始日期: 86/07/12 
      細(xì)胞濃度: 9x10 ^ 5細(xì)胞/ ml 
      使用的抗生素:免費支原體,細(xì)菌和真菌的檢測均為陰性。經(jīng)測試同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。
       






    •  
    •  
    •  
    •  
    •  

    [這批的文化條件。

    • 培養(yǎng)基: RPMI1640 + FCS 10%
      通過方法: 稀釋。
      生長溫度: 37 
      細(xì)胞傳代數(shù): 5x10 ^ 5細(xì)胞/毫升
      其他說明: 確保安培數(shù)足夠多。






    •  
    •  
    •  
    •  
    •  

    [附加數(shù)據(jù)]

     

      下載日期: 2008-06-13)

       

      [批號:111787:分銷(JCRB0086)]
       
      • 通道號, P5 * 
        細(xì)胞培養(yǎng)的開始日期: 11/17/87 
        安瓿中細(xì)胞的濃度: 2.8x10 ^ 6細(xì)胞/ ml 
        使用的抗生素:免費支原體,細(xì)菌和真菌的檢測均為陰性。經(jīng)測試的同工酶,G6PD,LD,NP。
         






      •  
      •  
      •  
      •  
      •  

      [這批的文化條件。

      • 培養(yǎng)基: RPMI1640 + FCS 10%
        通過方法: 稀釋。
        生長溫度: 37 
        細(xì)胞數(shù): 5x10 ^ 5細(xì)胞/ ml 
        附加說明: 冷凍前活力為84%。






      •  
      •  
      •  
      •  
      •  

      [附加數(shù)據(jù)]

       

        下載日期: 2008-06-13)

         

        [批號:062994:分銷(JCRB0086)]
         
        • 傳代號, P6 * 
          開始細(xì)胞培養(yǎng),無需克隆之前的庫存。
          開始細(xì)胞培養(yǎng)的日期: 94/08/94 
          安瓿中細(xì)胞的濃度: 1.02x10 ^ 7細(xì)胞/ ml 
          生長速率: 36.2小時
          顯微鏡下生存力(%): 79.6 
          使用的抗生素:免費
          支原體,細(xì)菌和真菌的檢測負(fù)。經(jīng)測試的同工酶,G6PD(typeB),LDH,NP。錨固依賴性:小區(qū)標(biāo)識:可用 
           







        •  
        •  
        •  
        •  
        •  

        [這批的文化條件。

        • 培養(yǎng)基: 含有10%熱滅活胎牛血清的RPMI1640培養(yǎng)基(JR Scientific,CO19407)。傳代
          方法: 簡單稀釋法。
          生長溫度: 37 C傳代
          細(xì)胞數(shù): 1.3x10 ^ 5細(xì)胞/ ml






        •  
        •  
        •  
        •  
        •  

        [附加數(shù)據(jù)]

         

        STR-PCR(1),
        •  STR-PCR(2),

        下載日期: 2008-06-13)



        cellroot.dbfcellspec.dbf導(dǎo)出。

        參考文獻(xiàn)

        1. 肯塔基州小川市,柴田市,田野清洲,伊野口市,Y。岸田,石本市和安達(dá)市。人類免疫缺陷病毒vpr開放閱讀框的變異分析, J。Virol。,63:4110-4114,1989。

         

        • 注意:通過重組DNA技術(shù)將突變引入人免疫缺陷病毒1型傳染性分子克隆的vpr開放閱讀框。在幾種人類CD4 +淋巴細(xì)胞細(xì)胞系中研究了這些變化對從轉(zhuǎn)染細(xì)胞中重新整合的病毒的復(fù)制和細(xì)胞病理學(xué)特性的影響。在所有情況下,突變病毒均具有傳染性和細(xì)胞致病性。但是,當(dāng)使用低投入劑量時,突變體的生長速度明顯快于野生型病毒。vpr突變體的生長動力學(xué)不同于vif和vpu突變體。
          參考編號:710

           

        2. I. Miyoshi,S. Hiraki,T. Tsubota,T. Kubonishi,I. Matsuda,Y.,Nakayama,T. Kishimoto,H.和Kimura,I. 源自急性淋巴細(xì)胞白血病的人B細(xì)胞,T細(xì)胞和空細(xì)胞白血病細(xì)胞系,《 自然》,267:843-844,1977。

         

        • 注意:盡管已經(jīng)從急性和慢性骨髓性白血病和急性淋巴細(xì)胞性白血病(ALL)的患者中獲得了幾種白血病細(xì)胞系,但人類白血病細(xì)胞的連續(xù)培養(yǎng)仍然是一項艱巨的任務(wù)。我們在這里描述了從三名ALL患者中新建立的B細(xì)胞,T細(xì)胞和空細(xì)胞白血病細(xì)胞系。
          參考ID:1878

           

        3. S. Hiraki,I。Miyoshi,I。Kubonishi,Matsuda,Y。,中山,T.,Kishimoto,H.,Machida,K.,Masuji,H.和Kimura,I。從人淋巴肉瘤建立T細(xì)胞系, Gann,69:115-118,1978。

         

        • 注意:在患有T細(xì)胞性limphosarcoma白血病的患者的骨骼狹窄處,通過連續(xù)培養(yǎng)建立了稱為TALL-1的白血病T細(xì)胞系。TALL-1細(xì)胞具有T細(xì)胞特性,缺乏Epstein-Barr病毒或其基因組。根據(jù)TALL-1細(xì)胞的細(xì)胞遺傳學(xué),形態(tài)學(xué)和表面特征,認(rèn)為它們起源于供體的白血病細(xì)胞。
          參考編號:1879

         

        NoteName of CellRegistry No.AnimalTissueDescription
         0-9Page Top   
         104C1JCRB9036guinea pigfetal bodyfetal carcass, benzo(a)pyrene transformed, diploid
         16-8JCRB0013mouseantibody-producing hybridomaanti-human erythrocyte, IgM
         19-7JCRB0014mouseantibody-producing hybridomaanti-human erythrocyte, IgM
         293JCRB9068humankidneytransformed embryonal kidney by adenovirus (type5)
         3LLJCRB1348mouselungLewis lung cancer-derived cell line, (C57BL mouse)
         3'-mRLh-2JCRB0431ratliverhepatoma, (Donryu rat)
         3'-mRLN-30JCRB0421ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
         3'-mRLN-31JCRB0422ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
         3T3 L1JCRB9014mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
         3T3-L1IFO50416mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
         3T3-Swiss albinoIFO50417mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
         3T3-Swiss albinoJCRB9019mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
         3T6-Swiss albinoJCRB9059mouseembryofibroblast, collagen-secreting, (Swiss albino mouse)
         3Y1-B Clone 1-6JCRB0734ratembryofibroblast, whole embryo, (Fischer 344 rat)
         4-2DJCRB0084mouseantibody-producing hybridomaanti-primase complexed with DNA polymerase alpha
         4-8HJCRB0083mouseantibody-producing hybridomaanti-DNA polymerase alpha, IgG1
         4G12 hybridomaIFO50090mouse x humanantibody-producing hybridoma4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
         5RP7IFO50277ratembryofibroblast transformed by c-Ha-ras oncogene
         6-23 clone 6IFO50270ratthyroidmedullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
         77N1IFO50280ratkidneytransformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
         7D4JCRB9092mouse x ratantibody-producing hybridomaanti-murine IL-2 receptors (rat antibody)
         8305CJCRB0824humanthyroidthyroid anaplastic carcinoma, undifferentiated
         8505CJCRB0826humanthyroidthyroid carcinoma, undifferentiated
         9-15cJCRB1181mousebone marrowmesenchymal cell line
         APage Top   
         A1IFO50519mouseneuralderives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
         A-172JCRB0228humanneuralglioblastoma
         A2058IFO50276humanmelanomamalignant melanoma, metastasis to lymph node
         A2B5 clone 105IFO50284mouseantibody-producing hybridomaA2B5 antibody, recognizing a glycolipid expressed in neural tissue
         A3/KAWJCRB0101humanhemo-lymphocyticlymphoma, malignant
         A31-1-1JCRB1356mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
         A31-714 C4IFO50021mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
         A4/FukJCRB0097humanhemo-lymphocyticlymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
         A-431IFO50411humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF receptor
         A-431JCRB0004humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
         A-431JCRB9009humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
         A549IFO50153humanlung (cancer)adenocarcinoma
         A549JCRB0076humanlung (cancer)adenocarcinoma
         A9JCRB0211mouseskinskin fibroblast, 8-azaguanine-resistant, (C3H mouse)
         A9(0439)-1JCRB0732human chromosome-introducedhuman chromosomal hybridcontains human chromosome Xpter>Xq26::3p12>3pter
         A9(2621)-4JCRB0730human chromosome-introducedhuman chromosomal hybridcontains human chromosome 12pter>12q24::Xq22>Xqter
         A9(3552)-2JCRB0731human chromosome-introducedhuman chromosomal hybridcontains human chromosome 11pter>11q23::Xq26>Xqter
         A9(3884)-1JCRB0729human chromosome-introducedhuman chromosomal hybridcontains human chromosome 16pter>16q24::Xq26>Xqter
         A9(7151)-3JCRB0728human chromosome-introducedhuman chromosomal hybridcontains human chromosome 17pter>17q11::Xq11>Xqter
         A9(An4)-2JCRB0727human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 1
         A9(Bsr10)JCRB2210human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #10
         A9(BsrX)JCRB2223human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome X
        *8)A9(Hygro13)JCRB2213human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #13
        *8)A9(Hygro14)JCRB2214human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #14
        *8)A9(Hygro21)JCRB2221human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #21
        *8)A9(Hygro22)JCRB2222human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #22
         A9(Neo1)JCRB2201human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 1
         A9(neo11)JCRB2211human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #11
         A9(Neo12)JCRB2212human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #12
         A9(Neo15)JCRB2215human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #15
         A9(Neo16)JCRB2216human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #16
        *8)A9(Neo17)JCRB2217human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #17
         A9(Neo18)JCRB2218human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #18
         A9(Neo19)JCRB2219human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #19
         A9(Neo2)JCRB2202human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 2
         A9(Neo20)JCRB2220human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #20
         A9(Neo3)JCRB2203human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 3
         A9(Neo4)JCRB2204human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 4
         A9(Neo5)JCRB2205human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 5
         A9(Neo6)JCRB2206human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 6
         A9(Neo7)JCRB2207human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 7
         A9(Neo8)JCRB2208human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 8
         A9(NTI8)-2JCRB0726human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 7
         ABC-1JCRB0815humanlung (cancer)adenocarcinoma
         Ac2FJCRB0408ratlivernormal liver, diploid, (Donryu rat)
         Ac2F(DT)JCRB0416ratliverAc2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
         Ac2F(ST)JCRB0417ratliverAc2F-derived, spontaneously transformed, (Donryu rat)
         Ad12-3Y1-Z19JCRB0737ratembryo3Y1 derivative, Ad12-transformed, (Fischer rat)
         AH601(JTC27)JCRB0132.1ratlivertransplantable ascites hepatoma, (Donryu rat)
         AH601.P3(JTC27)JCRB0132.2ratlivertransplantable ascites hepatoma, serum-free, (Donryu rat)
         AH601.P3(JTC27)JCRB0132.3ratlivertransplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
         AH66tcJCRB0411ratliverascites hepatoma, (Donryu rat)
         AH70BtcJCRB0412ratliverascites hepatoma, (Donryu rat)
         AH-7974.P3JCRB0714.1ratliverascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
         AIGJCRB1105hamster, Chineselunganchorage-independent mutant of CHL
         Alexander cellsIFO50069humanliver, gallbladderhepatoma, HBs antigen-positive
         AM-38IFO50492humanneuralglioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
         AP-16IFO50424mouseneuralastrocyte-progenitor cell line, (C3H/He mouse)
         AR-EcoScreenJCRB1328hamster, Chineseovaryandrogen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
         ARLJ301-3JCRB0248ratliverliver epithelial cell, (F344/DuCrj rat)
         ASF-4-1IFO50418humanskinskin, normal diploid fibroblast
         ASF-4-2IFO50419humanskinskin, normal diploid fibroblast
         ASH-3JCRB1073humanthyroidthyroid anaplastic carcinoma
        *2)AT(L)5KYJCRB0331humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
        *2)AT(L)6KYJCRB0332humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
        *2)AT(L)7KYJCRB0333humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
        *2)AT1OSJCRB0308humanskinataxia telangiectasia, fibroblast
        *2)AT2KYJCRB0316humanskinataxia telangiectasia, fibroblast
         AtT-20JCRB9098mousepituitarypituitary tumor, ACTH producing, (LAF1 mouse)
         AZ-521JCRB0061humanstomachoriginally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
         BPage Top   
         B-1JCRB0243mousetestisLeydig cell tumor, estrogen-dependent, (BALB/c mouse)
         B104JCRB0117humanhemo-lymphocyticlymphoma, malignant B lymphoma
        *1)B104-R3JCRB0117.1humanhemo-lymphocyticlymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
         B16 melanomaJCRB0202mousemelanomamelanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
         B2-17IFO50361humanneuralastrocytoma, thymidine kinase-deficient mutant of U251 MG cells
         B8/3JCRB0238mousehemo-lymphocyticerythroleukemia
         B82JCRB0212mouseskinskin fibroblast, bromodeoxyuridine-resistant
         B95-8JCRB9123cotten-top tamarinhemo-lymphocyticEBV transformed, release EBV infectious to primates
         BALB/3T3 A31-1-1JCRB0601mouseembryofibroblast, contact inhibited, (BALB/c mouse)
         BALB/3T3 clone A31JCRB9005mouseembryofibroblast, contact inhibited, (BALB/c mouse)
         Balb/3T3-A31-1-1IFO50070mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
         Balb/c 3T3 A31-1-13IFO50299mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
         Balb/c 3T3 A31-I-1IFO50298mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
         BALB-MCJCRB0233.0mousemammarymammary cancer, (BALB/cHe mouse)
         BALB-MC.D3JCRB0233.1mousemammarymammary cancer, (BALB/cHe mouse)
         BALB-MC.E12JCRB0233.2mousemammarymammary cancer, (BALB/cHe mouse)
         BALL-1JCRB0071humanhemo-lymphocyticleukemia, acute lymphoblastoid
         BCE C/D-1bJCRB9129bovinecorneanormal corneal epithelial cell, production of extracellular matrix proteins
         BCL1 Clone CW13.20JCRB9117mousehemo-lymphocyticleukemia, B cell, (BALB/c mouse)
        *2)BCNS1KOJCRB0324humanskinbasal cell nevus syndrome, fibroblasts
         BeckerIFO50289humanneuralastrocytoma, GFAP-negative
         BeWoJCRB9111humanplacentachorio carcinoma, trophoblastic cell line
         Bhas 42JCRB0149mouseembryoH-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
         BHK-21(C-13)JCRB9020hamster, Syriankidneykidney, subclone of BHK-21
         BOKUIFO50323humanuterine cervixcervical squamous cell carcinoma
         BRL-3AJCRB0025ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
         BRL-3AJCRB9114ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
        *2)BS2CHJCRB0317humanskinBloom's syndrome, fibroblast
         BS2CHTERTJCRB1061humanskinBloom's syndrome, fibroblast, immortalized by hTERT
         BS-C-1IFO50413monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
        *1)BS-C-1JCRB9011monkey, African greenkidneykidney
         BS-C-1JCRB9126monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
         BSL2KAJCRB1042humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
         BW5147.G.1.4.OUA-R.1JCRB9002mousehemo-lymphocyticlymphoma, T cell lymphoma, (AKR/J mouse)
         CPage Top   
         C32TGJCRB0227humanmelanomaskin amelanotic melanoma, 6-thioguanine-resistant
        *1)C3H/10T1/2 clone 8JCRB0602mouseembryofibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
         C3H/10T1/2 clone 8JCRB9080mouseembryofibroblast, contact inhibited, (C3H mouse)
         C3H/10T1/2-clone 8JCRB0003mouseembryofibroblast, contact inhibited, (C3H mouse)
         C3H/10T1/2-clone8IFO50415mouseembryofibroblast, contact inhibited, (C3H mouse)
         C3H/MCA clone 15IFO50042mouseembryo3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
         C6IFO50110ratneuralglial tumor, GFAP-positive
         C6JCRB9096ratneuralglial tumor, GFAP-positive
         C6/36IFO50010mosquitohatched larvaeuseful for replication of flavivirus
         C6-SF2IFO50425ratneuralC6 subline adapted to serum-free medium
         Ca SkiIFO50007humanuterine cervixcervical epidermoid cancer
         Ca9-22JCRB0625humanoralsquamous carcinoma, gingiva
         Caki-1JCRB0801humankidneyrenal clear cell carcinoma
         CaR-1JCRB0207humanrectumadenocarcinoma
        *1)CCD 841 CoNIFO50482humancolonestablished from normal colonic tissue, epithelial-like, (distribution finished)
         CCD-14BrJCRB9101humanlungbronchus, diploid
         CCD-33CoIFO50483humancolonestablished from normal colon, fibroblast, (the lot in cellbank does not grow)
         CCK-81JCRB0208humancolonadenocarcinoma
         CCRF S-180 IIJCRB9089mousesarcomaS-180 sarcoma derivative
         CCRF-CEMIFO50412humanhemo-lymphocyticleukemia, acute T lymphoblastic
         CCRF-CEMJCRB0033humanhemo-lymphocyticleukemia, acute T lymphoblastic
         CCRF-CEMJCRB9023humanhemo-lymphocyticleukemia, acute T lymphoblastic
         CCRF-HSB2JCRB0031humanhemo-lymphocyticleukemia, acute T lymphoblastic
         CCRF-SBIFO50026humanhemo-lymphocyticleukemia, acute B lymphoblastic
         CCRF-SBJCRB0032humanhemo-lymphocyticleukemia, acute B lymphoblastic
         Ch 1 EsJCRB9037goatesophagusesophagus
         Chang LiverIFO50016humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
         Chang LiverJCRB9066humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
         CHL/IUJCRB0030hamster, Chineselungnormal
        *8)CHO(His9)JCRB2209human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 9
         CHO(pMAM-HSluc)JCRB0136.2hamster, ChineseovarypMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
         CHO(pMAM-luc)JCRB0136.1hamster, ChineseovarypMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
         CHO/HGPRTJCRB0218hamster, ChineseovaryHPRT-deficient CHO cell line
         CHO-K1IFO50414hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
         CHO-K1JCRB9018hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
         CKT-1IFO50003bovinekidneyuseful to assay bovine adenovirus 3
         CKT-1JCRB0008bovinekidneyuseful to assay bovine adenovirus 3
         CMK-11-5IFO50430humanhemo-lymphocyticleukemia, acute megakaryoblastic
         CMK-86IFO50428humanhemo-lymphocyticleukemia, acute megakaryoblastic
         CoCM-1JCRB0257humancolonadenocarcinoma
         COLO201JCRB0226humancolonadenocarcinoma
         COLO320 DMJCRB0225humancolonadenocarcinoma
         COS-1JCRB9082monkey, African greenkidneySV40 transformed African green monkey kidney
         COS-7IFO50068monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
         COS-7JCRB9127monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
        *1)CPAIFO50272bovinevascular systempulmonary artery normal endothelial cell
         CPAJCRB9025bovinevascular systempulmonary artery normal endothelial cell
         CPAEJCRB9022bovinevascular systempulmonary artery normal endothelial cell
         CPT-K5JCRB1067humanhemo-lymphocyticleukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
         CRFKJCRB9035catkidneykidney, BVD antigen negative
         cs-17-25JCRB1102hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
         cs-19-36JCRB1103hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
         cs-20-5JCRB1104hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
        *2)CS2AWJCRB0310humanskinCockayne's syndrome, fibroblast
         CS2AWTERTJCRB1059humanskinCockayne's syndrome, fibroblast, immortalized by hTERT
        *2)CS2OSJCRB0309humanskinCockayne's syndrome, fibroblast
         CS2OS(SVT)JCRB1056humanskinCockayne's syndrome, fibroblast, immortalized by SV40 large T
         CV-1JCRB9049monkey, African greenkidneykidney, highly susceptible to SV40 infection
         c-WRT-7-LRJCRB0168rathemo-lymphocyticRLV infected myelomonocytic leukemia.
         DPage Top   
        *1)D422TJCRB9112humansarcomabenign abdominal desmoid tumor
         DaudiJCRB9071humanhemo-lymphocyticlymphoma, Burkitt's
         DBC1.2IFO50484mouseolfactory epitheliumdark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
         DD-762JCRB1077mousemammarymammary tumor, producing MuMTV, (DD/Tbr mouse)
         De GinJCRB9078humanskinosteoporosis, skin
         delta-47JCRB1344humanhemo-lymphocyticmyeloma, secreting IgD
        *1)DempseyJCRB9088humanskinKlinefelter's syndrome, skin
         Detroit 510JCRB9104humanskingalactosemia, skin
         Detroit 525JCRB9102humanskinTurner's syndrome, skin
        *1)Detroit 529JCRB9043humanskinDown's syndrome, skin
         Detroit 532JCRB9044humanskinDown's syndrome, foreskin
         Detroit 539JCRB9045humanskinDown's syndrome, skin
         DIG104.10H.1JCRB1213.3mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG1(k)
         DIG222.4D.5JCRB1213.2mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG2b(k)
         DL-40JCRB1337humanhemo-lymphocyticlymphoma, non-Hodikin's, Ki-1-positive
         DLD-1JCRB9094humancolonadenocarcinoma
         dRLa-74 Clone 2JCRB0409ratliverliver adenoma, (Donryu rat)
         dRLh-84JCRB0410ratliverhepatoma, (Donryu rat)
         dRLN-4JCRB0418ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
         dRLN-6JCRB0420ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
         dRLN-9JCRB0419ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
         DSPT200JCRB0217hamster, Syrianembryofetus fibroblast transformed cell
         DT40JCRB9130chickenhemo-lymphocyticavian leukosis virus (ALV)-induced lymphomas
         EPage Top   
         E1A-3Y1-1JCRB0738ratembryo3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
        *1)EB-3IFO50028humanhemo-lymphocyticeliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
         EBC-1JCRB0820humanlung (cancer)squamous cell carcinoma
         EBTr (NBL-4)JCRB9038bovinelungembryonic trachea
        *5)ECV304JCRB0744humanvascular systemimmortalized normal endothelium, contamination by T-24/EJ1 was suspected.
         EGV-4TJCRB0229ratlungimmortal cell line from MNNG-transformed tracheal epithelial cells
         Ehrlich ascitesJCRB9090mouseascitesEhrlich-Lettre ascites carcinoma
         EHSIFO50268mousesarcomachondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
         EJ-1JCRB0710humanbladderbladder carcinoma, contamination by T24 cells has been suspected
         Ex-3LLJCRB1349mouselungLewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
         FPage Top   
         F119JCRB1324mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
         F2408IFO50015ratembryofibroblast-like, (Fischer rat)
         F2408 EBNA2 cl-14JCRB0143.5ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-16JCRB0143.2ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-18JCRB0143.3ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-23JCRB0143.6ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-24JCRB0143.4ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-28JCRB0143.7ratembryoEBNA2-transfected, (Fischer rat)
         F2408 EBNA2 cl-9JCRB0143.1ratembryoEBNA2-transfected, (Fischer rat)
         F2408 pZipNeoJCRB0143.0ratembryopZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
         F2408-B812IFO50099ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
         F2408-B993IFO50100ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
         F2408-No.20IFO50101ratembryothymidine kinase-deficient F2408 cell line, (Fischer rat)
         F2408-No.3IFO50098ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
         F2408-No.7IFO50102ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
         F25JCRB1323mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
         F56JCRB1189mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
         F9JCRB0721mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
         F9-41JCRB0001mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
        *2)FA18JTOJCRB0315humanskinFanconi's anemia, fibroblast
        *2)FA9JTOJCRB0314humanskinFanconi's anemia, fibroblast
         FA9JTOTERTJCRB1060humanskinFanconi's anemia, fibroblast, immortalized by hTERT
         FAA-HTC1JCRB0249ratliverhepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
         FBHEIFO50154bovinevascular systemheart normal endothelial cell, FGF-dependent for survival
         FF101JCRB1040ratliverhepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
         FHs 74 IntJCRB9076humanintestinefetal small intestine, normal, (not intestinal epithelial cell)
        *1)FL*JCRB9016humanHeLa-contaminantoriginally established from amnion, HeLa-contaminated
         FLAM-76JCRB1346humanhemo-lymphocyticmyeloma, IL-6-dependent, growth is very slow
         Flow2000IFO50089humanlungfetal lung, normal diploid fibroblast
        *1)Flow2000JCRB0067humanlungfetal lung, normal diploid fibroblast (not available)
         Flow3000JCRB0068humanneuralnormal fibroblast
         Flow7000IFO50079humanskinskin, normal diploid fibroblast
         FLS3IFO50377mouseliverliver stromal cell line
         FLS5IFO50378mouseliverliver stromal cell line
         FM3AJCRB0701mousemammarymammary carcinoma, spontaneously obtained, (C3H/He mouse)
         FM3A APRT~JCRB0703mousemammarymammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
         FM3A HPRT~JCRB0702mousemammarymammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
         FM3A TK~JCRB0704mousemammarymammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
        *2)FPC15JTOJCRB0319humanskinfamilial polyposis coli, fibroblasts
        *2)FPC5JTOJCRB0318humanskinfamilial polyposis coli, fibroblasts
         FRSKJCRB0005ratskinepidermal keratinocyte line from fetal skin
         FS-1IFO50477humanbone marrow stromabone marrow stromal cell from a myelogenous leukemia patient
         FSthy21JCRB0719mousethymidylate defectivecomplete defective strain of thymidylate synthase, (C3H mouse)
         FU97JCRB1074humanstomachadenocarcinoma, poorly differentiated, AFP producing
         GPage Top   
         G-292 clone A141B1IFO50107humansarcomaosteosarcoma
         G-361IFO50009humanmelanomamalignant melanoma, skin
         G-361JCRB9074humanmelanomamalignant melanoma, skin
         G-401JCRB9065humankidneyWilms' tumor (embryonal carcinosarcoma of kidney)
         G-402JCRB9070humankidneyrenal leiomyoblastoma
         GAKIFO50321humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
         GAKJCRB0180humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
         GB-1IFO50489humanneuralglioma, GFAP, vimentin and fibronectin-positive
         GCH-nu-YSJCRB1201humanuterusgestational uterine choriocarcinoma
         GH1IFO50269ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
         GH1JCRB9046ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
         GH3IFO50105ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
         GH3JCRB9047ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
         GHBP116JCRB1226mouseantibody-producing hybridomaanti-human growth hormone receptor antibody-producing, subclass IgG1(k)
         GOTOJCRB0612humanneuralneuroblastoma, adrenal gland
         GOTO.P3JCRB0612.1humanneuralneuroblastoma, adrenal gland, serum-free
        *2)GP-1JCRB1366guinea pighemo-lymphocyticGuinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
         GP8JCRB1198mouseskinhuman beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
         GRSLIFO50111mousehemo-lymphocyticthymic leukemia, (GR/A mouse)
        *2)GS33JTOJCRB0322humanskinGardner's syndrome, fibroblasts, (M)
        *2)GS7OJTOJCRB0323humanskinGardner's syndrome, fibroblasts
         HPage Top   
         HARAJCRB1080.0humanlung (cancer)squamous carcinoma, PTHrP producing
         HARA-BJCRB1080.1humanlung (cancer)squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
         HCA-1JCRB1153humanuterine cervixendocervical adenocarcinoma endocervical adenocarcinoma cell line.
        *4)HCC-56JCRB1037humancolonadenocarcinoma, moderately differentiated
         HCS-2JCRB1203humanuterine cervixcervical squamous cell carcinoma
         HCSC-1JCRB1205humanuterine cervixendocervical small cell carcinoma
        *2)HCT-2JCRB1362hamster, Syrianhemo-lymphocyticHamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
         HD-70JCRB1335humanhemo-lymphocyticlymphoma, from Hodgkin's
         HE-1IFO50297humanembryowhole fetus, normal diploid fibroblast
         HEC-1JCRB0042humanuterusendometrial adenocarcinoma
         HEC-108JCRB1123humanuterusendometrial adenocarcinoma
         HEC-116JCRB1124humanuterusendometrial adenocarcinoma
         HEC-151JCRB1122humanuterusendometrial adenocarcinoma
        *5)HEC-155JCRB1127humanuterusendometrial adenocarcinoma, (distribution was suspended)
         HEC-1-AJCRB1117humanuterusendometrial adenocarcinoma
         HEC-1-BJCRB1193humanuterusendometrial adenocarcinoma
         HEC-251JCRB1141humanuterusendometrial adenocarcinoma
         HEC-265JCRB1142humanuterusendometrial adenocarcinoma
         HEC-50BJCRB1145humanuterusendometrial adenocarcinoma
         HEC-59JCRB1120humanuterusendometrial adenocarcinoma
         HEC-6JCRB1118humanuterusendometrial adenocarcinoma
         HEC-88nuJCRB1121humanuterusendometrial adenocarcinoma
         HELJCRB0062humanhemo-lymphocyticleukemia, erythroid
         HeLaJCRB9004humanuterine cervixepitheloid carcinoma
         HeLa 229JCRB9086humanuterine cervixepitheloid carcinoma
         HeLa AGJCRB0213humanuterine cervixepitheloid carcinoma, 8-azaguanine-resistant
         HeLa S3IFO50011humanuterine cervixcervical epithelioid carcinoma
         HeLa S3JCRB9010humanuterine cervixcervical epitheloid carcinoma, adaptable to a suspension culture
         HeLa S3 (sc)JCRB0713humanuterine cervixHeLa derivative, can grow in suspension culture
         HeLa TGJCRB0214humanuterine cervixepitheloid carcinoma, 6-thioguanine-resistant
         HeLa TG CapJCRB0215humanuterine cervixepitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
         HeLa.P3JCRB0649humanuterine cervixserum free adapted HeLa cell line
         HeLa.P3JCRB0649.1humanuterine cervixserum free adapted HeLa cell line, deposited by original developer
         HeLa.P3(S)JCRB0606humanuterine cervixHeLa cell derived, can grow in a serum-free medium
         HeLa9903JCRB1318humanuterine cervixhERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
         Hep G2JCRB1054humanliver, gallbladderhepatoma
         HEPMJCRB9095humanoralembryonic palatal mesenchyme, limited life span
         HFb16dJCRB1008humanskinnormal fibroblast transfected with HPV16
         HFL1IFO50074humanlungfetal lung, normal diploid fibroblast
         HGH1.1.3JCRB1222.01mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH1.11.1JCRB1222.08mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
         HGH1.15.3JCRB1222.09mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH1.17.2JCRB1222.03mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH1.31.3JCRB1222.12mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH1.32.4JCRB1222.13mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
         HGH1.35.2JCRB1222.04mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2a(k)
         HGH1.41.1JCRB1222.10mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
         HGH1.46.1JCRB1222.11mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
         HGH1.6.5JCRB1222.02mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH1.8.1JCRB1222.07mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
         HGH1.9.3JCRB1222.06mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH2.15.4JCRB1222.16mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(lambda)
         HGH2.4.2JCRB1222.15mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HGH2.6.1JCRB1222.05mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
         HHJCRB0099bovinevascular systemcarotid artery normal endothelial cell
         HKA-1JCRB1017humanskingiant keratoacanthoma
         HL60JCRB0085humanhemo-lymphocyticleukemia, acute promyelotic, differentiation-inducible
         HL-60IFO50022humanhemo-lymphocyticleukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
         HL60(S)JCRB0163humanhemo-lymphocyticleukemia, acute promyelotic
         HL60RGJCRB0006humanhemo-lymphocyticleukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
         HLCL-1JCRB0041humanhemo-lymphocyticlymphocyte, peripheral
         HLEJCRB0404humanliver, gallbladderhepatoma, non-differentiated
         HLFJCRB0405humanliver, gallbladderhepatoma, non-differentiated
         HM-1JCRB1208hamster, Syrianhemo-lymphocyticmacrophage line
         HMC-1-8JCRB0166humanmammarybreast cancer, target cell of the T-cell killer clone T(cHMC-1)
         HMY-1JCRB1018humanmelanomamalignant melanoma, sole, melanin production is poor
         HO-1-N-1JCRB0831humanoralsquamous carcinoma, buccal mucosa
         HO-1-u-1JCRB0828humanoralsquamous carcinoma, mouth floor
         HOSIFO50106humansarcomaosteosarcoma
         HPSV178-4-3JCRB1314mouseantibody-producing hybridomaHPSV178 antibody, against GPI-anchorless splice variant of prion protein
         HR-3Y1-2JCRB0743ratembryo3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
         hs-103-3JCRB1096hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         hs-164-2JCRB1097hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         hs-171-1JCRB1098hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         hs-172-3JCRB1099hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         hs-211JCRB1100hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         HS-22JCRB1215mousebone marrowmesenchymal stem cell line
         hs-222-3JCRB1101hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
         Hs68IFO50350humanskinskin, normal diploid fibroblast
         HSC-1JCRB1015humanskinsquamous carcinoma
         HSC-2JCRB0622humanoralsquamous carcinoma, mouth
         HSC-3JCRB0623humanoralsquamous carcinoma, tongue
         HSC-4JCRB0624humanoralsquamous carcinoma, tongue
         HSC-5JCRB1016humanskinsquamous carcinoma
         HSC-FJCRB1164monkey, Cynomolgushemo-lymphocyticHSV-immortalized T-cell line, susceptible to SIV
         HSGc-C5JCRB1070humanHeLa-contaminantoriginally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
         HSP-239JCRB1165chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
         HSP-250JCRB1177chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
         HSR-5JCRB1211monkey, rhesushemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
         HS-SultanJCRB9062humanhemo-lymphocyticestablished as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
         HT100JCRB0221hamster, Syrianlunglung, new born
         HT-1080IFO50354humansarcomafibrosarcoma, acetabulum
         HT-1080JCRB9113humansarcomafibrosarcoma, acetabulum
         HTC/C3JCRB0164humanthyroidthyroid carcinoma
         HuCCT1JCRB0425humanliver, gallbladderbile duct carcinoma
        *8)huH-1JCRB0199humanliver, gallbladderhepatoma, HBs antigen-positive, HBc(-), HBe(-).
         HuH28JCRB0426humanliver, gallbladderbile duct carcinoma
         HUH-6 Clone 5JCRB0401humanliver, gallbladderhepatoblastoma, well differentiated
         HuH-7JCRB0403humanliver, gallbladderhepatoma, differentiated
        *1)Human Mucosal cellsJCRB9116humancoloncolon
         HuO-3N1JCRB0413humansarcomaosteosarcoma, ilium
         HuO9JCRB0427humansarcomaosteosarcoma
         HuO9N2JCRB0428humansarcomaosteosarcoma
         HUV-EC-CIFO50271humanvascular systemnormal endothelial cell, umbilical cord
         IPage Top   
         I-10JCRB9097mousetestisLeydig cell testicular tumor (BALB/cJ mouse)
         I51TJCRB1225mouseskindeficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
         IAR-20JCRB0610ratlivernon-transformed live cell line, (BD-IV rat)
         IHH-4JCRB1079humanthyroidthyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
         IM-9IFO50025humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
         IM-9JCRB0024humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
         IM95JCRB1075.0humanstomachadenocarcinoma, moderately differentiated
         IM95mJCRB1075.1humanstomachadenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
         IMR-32IFO50283humanneuralneuroblastoma
         IMR-32JCRB9050humanneuralneuroblastoma
        *4)IMR-90JCRB0516humanlungfetal lung, normal diploid fibroblast
         IMR-90JCRB9054humanlungfetal lung, normal diploid fibroblast
         IMR-90-40JCRB0519humanlungfetal lung, normal diploid fibroblast, PDL=about 40
        *3)IMR-90-50JCRB0520humanlungfetal lung, normal diploid fibroblast, PDL=about 50
         Indian MuntjacJCRB9100Indian Muntjakskinused for chromosomal study
         IT-26R21IFO50078ratthymusT cell differentiation factor producing, (Wistar rat)
         IT-45R1IFO50076ratthymusT cell differentiation factor producing, (Wistar rat)
         IT-45R91IFO50077ratthymusthymic fibroblast, (Wistar rat)
         IT-79MTNC3IFO50248mousethymusthymic nurse cell, (BALB/c mouse)
         ITO-IIJCRB0613humantestistesticular tumor, (embryonal tumor)
         JPage Top   
         J-111IFO50005humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
         J-111JCRB0073humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
         J774.1JCRB0018mousehemo-lymphocyticmonocyte-macrophage, IL-1-producing, (BALB/c mouse)
         J774A.1JCRB9108mousehemo-lymphocyticmonocyte-macrophage, (BALB/c mouse)
        *6)JHH-1JCRB1062humanliver, gallbladderhepatoma
        *6)JHH-2JCRB1028humanliver, gallbladderhepatoma
        *6)JHH-4JCRB0435humanliver, gallbladderhepatoma
        *6)JHH-5JCRB1029humanliver, gallbladderhepatoma
        *6)JHH-6JCRB1030humanliver, gallbladderhepatoma
        *6)JHH-7JCRB1031humanliver, gallbladderhepatoma, HBV-integration
         JKT-beta-delJCRB0147humanhemo-lymphocyticleukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
         JTC-11JCRB0424mouseascitesEhrlich ascites
         JTC-16 P3JCRB0714ratliverascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
         JTC19JCRB0608ratlunglung, (JAR-1 rat)
         KPage Top   
         K562JCRB0019humanhemo-lymphocyticleukemia, chronic myelogenous, differentiation-inducible
         K562/ADMJCRB1002humanhemo-lymphocyticleukemia, chronic myelogenous, adriamycin resistant derivative of K562
         KAI3IFO50518humanhemo-lymphocyticEBV-infected NK-like cell line, IL-2 dependent
         KALS-1IFO50434humanneuralglioma, GFAP, vimentin and CD13-positive
         Kasumi-1JCRB1003humanhemo-lymphocyticleukemia, acute myeloid
         Kasumi-3JCRB1004humanhemo-lymphocyticleukemia, acute myeloperoxidase-negative
         Kasumi-6JCRB1024humanhemo-lymphocyticleukemia, acute myeloid
         KATOIIIJCRB0611humanstomachsignet ring cell carcinoma
         KBJCRB9027humanHeLa-contaminantoriginally established from oral epidermoid carcinoma, HeLa-contaminated
         KCL-22JCRB1317humanhemo-lymphocyticleukemia, chronic myelocytic, Ph1-positive
         KDJCRB9103humanoralfibroblast, lip
         KG-1JCRB0065humanhemo-lymphocyticleukemia, acute myeloblastic
         KG-1JCRB9051humanhemo-lymphocyticleukemia, acute myelogenous
         KG-1-CJCRB0236humanneuralmixed glioma, GFAP-negative, S-100-positive
         KHM-10BJCRB0165humanhemo-lymphocyticlymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
         KHM-1BJCRB0133humanhemo-lymphocyticmyeloma, multiple, with hyperamylasemia.
         KHM-3SJCRB0138humanlung (cancer)small cell carcinoma, HTLV-1gene integration
         KHM-5MJCRB0148humanthyroidthyroid carcinoma, undifferentiated, IL-8 producing
         KHYG-1JCRB0156humanhemo-lymphocyticleukemia, NK cell-like, IL-2 dependent
         Ki-JKJCRB1065humanhemo-lymphocyticlymphoma, anaplastic giant cell, Ki-1(CD30)-positive
         KINGS-1IFO50435humanneuralastrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
         KMBC-2JCRB1148humanbladderurinary bladder carcinoma
         KMH-2JCRB1066humanthyroidthyroid anaplastic carcinoma
         KML-1JCRB1347humanhemo-lymphocyticlymphoma, non-Hodgkins
         KMLS-1JCRB0200humansarcomaliposarcoma
         KMM-1JCRB1180humanhemo-lymphocyticmyeloma
         KMPC-3JCRB1150humankidneycell line derived from renal pelvis
         KMRC-1JCRB1010humankidneyrenal clear cell carcinoma
         KMRC-2JCRB1011humankidneyrenal clear cell carcinoma
         KMRC-20JCRB1071humankidneyrenal cancer
         KMRC-3JCRB1012humankidneyrenal clear cell carcinoma (growth is very slow)
        *4)KMRC-5JCRB1007humankidneyrenal clear cell carcinoma
         KMRM-M1JCRB1014humankidneyrenal carcinoma
         KMS-11JCRB1179humanhemo-lymphocyticmyeloma, multiple, IgG kappa-secreting, EBNA(-)
         KMS-12-BMJCRB0429humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
         KMS-12-PEJCRB0430humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
         KMS-20JCRB1196humanhemo-lymphocyticmyeloma
         KMS-21BMJCRB1185humanhemo-lymphocyticmyeloma
         KMS-26JCRB1187humanhemo-lymphocyticmyeloma
         KMS-27JCRB1188humanhemo-lymphocyticmyeloma
         KMS-28BMJCRB1192humanhemo-lymphocyticmyeloma
         KMS-28PEJCRB1191humanhemo-lymphocyticmyeloma
         KMS-34JCRB1195humanhemo-lymphocyticmyeloma
         KMS-6JCRB0432humanembryofibroblast, normal diploid
         KMST-6JCRB0433humanembryofibroblast, immortalized by 60Co irradiation, derivative of KMS-6
        *1)KMST-6/TJCRB0434humanembryofibroblast, immortalized after extensive passages, derivative of KMS-6
         KNS-42IFO50356humanneuralglioma, GFAP-positive, S-100 and NSE-negative
         KNS-60IFO50357humanneuralglioma, GFAP, S-100 and NSE-negative
         KNS-62IFO50358humanlung (cancer)bronchial squamous carcinoma, metastasis to brain
         KNS-81IFO50359humanneuralglioma, GFAP and S-100-positive, NSE-negative
         KNS-81-FDIFO50444humanneuralglioma, derivative of KNS-81 adapted to serum-free medium
        *1)KNS-89IFO50360humanneuralgliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
        *5)KO51JCRB0122humanhemo-lymphocyticleukemia, acute myeloblastic, contamination of K562 has been suspected.
         KO52JCRB0123humanhemo-lymphocyticleukemia, acute myeloblastic
         KONJCRB0194humanoralsquamous carcinoma, mouth, ras P21 expression
         KOSC-2 cl3-43JCRB0126.1humanoralsquamous carcinoma, stage III, oral floor
        *5)KOSC-3JCRB0127humanoralsquamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
        *5)KP-1NJCRB0177.0humanpancreaspancreatic cancer, adenocarcinoma (distribution is suspended)
        *5)KP-1NLJCRB0177.1humanpancreaspancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
         KP-2JCRB0181humanpancreaspancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
         KP-3JCRB0178.0humanpancreaspancreatic cancer, adenosquamous carcinoma
         KP-3LJCRB0178.1humanpancreaspancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
         KP-4JCRB0182humanpancreaspacnreatic ductal cell carcinoma, secreting PTHrP
         KP-N-RT-BM-1IFO50432humanneuralneuroblastoma, from bone marrow, neuronal and Schwannian differentiation
         KP-N-SI9sIFO50433humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
         KP-N-YNIFO50431humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
         KS-1IFO50436humanneuralglioblastoma
         KT-5IFO50161mouseneuralastrocyte line, GFAP-positive, (C3H/He mouse)
         KU812IFO50363humanhemo-lymphocyticleukemia, chronic myeloid
         KU812JCRB0104humanhemo-lymphocyticleukemia, chronic myeloid
         KU812EJCRB0104.1humanhemo-lymphocyticleukemia, chronic myeloid
         KU812FJCRB0104.2humanhemo-lymphocyticleukemia, chronic myeloid
         KUM10JCRB1176mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM3JCRB1134mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM4JCRB1135mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM5JCRB1178mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM6JCRB1202mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM7JCRB1204mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUM9JCRB1139mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KURAMOCHIJCRB0098humanovaryundifferentiated carcinoma, ascites
         KUSA-A1JCRB1119mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUSA-H1JCRB1129mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KUSA-OJCRB1132mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
         KY821JCRB0105humanhemo-lymphocyticleukemia, acute myeloid
         KY821A3JCRB0105.1humanhemo-lymphocyticleukemia, acute myeloid, subclone of KY821
         KYM-1JCRB0627humansarcomarhabdomyosarcoma, neck
        *6)KYSE110JCRB1064humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE140JCRB1063humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE150JCRB1095humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE170JCRB1082humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE180JCRB1083humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE220JCRB1086humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE270JCRB1087humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE30JCRB0188humanesophagussquamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE50JCRB0189humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        *6)KYSE70JCRB0190humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
         LPage Top   
         L alphaJCRB0125mouseskinL cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
         L cl 1DJCRB0722mouseskinfibroblast, thymidine kinase-deficient, (C3H mouse)
         L.P3JCRB0648mouseskinserum-free adapted L929 cell line
         L.P3(S)JCRB0605mouseskinL cell derived, can grow in a serum-free medium, (C3H mouse)
         L1210JCRB9026mousehemo-lymphocyticleukemia, lymphocytic, (DBA/2 mouse)
         L-2JCRB9053ratlungadult lung
         L2CIFO50210guinea pighemo-lymphocyticleukemic cell, maintainable only by transplantation
         L5178YJCRB0709mousehemo-lymphocyticlymphoma, methylcholanthrene induced, (DBA/2 mouse)
         L5178Y TK+/-3.7.2cJCRB0709.1mousehemo-lymphocyticL5178Y derivative, thymidine kinase +/- heterozygotic line
         L5178Y ts2JCRB0723mousehemo-lymphocyticL5178Y derivative, abnormal cell division at non-permissive temperature
         L5178Y ts39JCRB0724mousehemo-lymphocyticL5178Y derivative, micronucleation at non-permissive temperature
         L6IFO50364ratmuscular systemskeletal muscle myoblast
         L6JCRB9081ratmuscular systemskeletal muscle myoblast
         L6TGJCRB0209ratmuscular systemskeletal muscle myoblast, 6-thioguanine-resistant
         L6TG CapJCRB0210ratmuscular systemskeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant

         

        上海起發(fā)實驗試劑有限公司
        地址:上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
        郵箱:xs1@78bio.com
        傳真:021-50724961
        關(guān)注我們
        歡迎您關(guān)注我們的微信公眾號了解更多信息:
        歡迎您關(guān)注我們的微信公眾號
        了解更多信息
        主站蜘蛛池模板: 国产免费踩踏调教视频| 久久精品国产亚洲av麻豆小说| 狼友看片| 中文字幕人妻一区二区三区| 插穴网站| 久久久久久AV| 福利无遮挡喷水高潮| 丝袜美腿视频一区二区三区 | 91制片厂天美传媒网站进入| 亚洲色欲在线播放一区| 97福利在线| 亚洲日产韩国一二三四区| 亚洲免费v片| 国产精品天堂蜜av在线播放| 伊人天天色| 揉着我的奶从后面进去视频| 久久久影院| 乱人伦xxxx国语对白| 四虎论坛| 成人区人妻精品一| 欧美丝袜你懂的| 国产精品久久国产精品99 gif| 中文字幕乱码亚洲精品一区| 自拍亚洲一区欧美另类| 欧美极品在线| 国产在线第四页| 印度成人AV| 欧美中文字幕影院| 国产亚洲精品久久久美女18黄| 日韩成人在线视频播放| 亚洲日韩欧美一区二区三区| 亚洲色大成网站WWW永久男同| 国产午夜无码福利在线看网站| 人妻中文字幕有码在线| 天天色欧美综合| 欧美人妖ⅩXXX极品另类| 囯产精品久久久久久久久久妞妞| 91色| 成av免费大片黄在线观看 | 国产人妻精品一区二区三区| 人人操超碰|